| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.63 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.6 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |